文献速递免疫规划卫生政策与健康促进

2018年1月至2019年10月赴英难民免疫状况:一项回顾性、基于人群的横断面研究

Immunisation status of UK-bound refugees between January, 2018, and October, 2019: a retrospective, population-based cross-sectional study.
PubMed 文献 · Lancet Public Health · 2022-05-28

该研究回顾性分析了2018年1月1日至2019年10月31日期间在18个国家接受国际移民组织(IOM)健康评估的12526名赴英难民,计算其记录疫苗覆盖率并与英国免疫规划及英国难民技术指南比较。结果显示出发赴英的6870名难民中,含麻疹成分疫苗至少一剂记录覆盖率为80.9%,脊灰疫苗为84.4%,而含白喉或破伤风成分疫苗仅19.1%。完全符合英国脊灰、麻疹、白喉和破伤风免疫规划的比率分别为11.1%、34.0%和5.5%,成人符合率显著低于儿童。

要点

  • 出发赴英难民中,含麻疹成分疫苗至少一剂记录覆盖率为80.9%,脊灰疫苗为84.4%,含白喉或破伤风成分疫苗仅19.1%。
  • 完全符合英国免疫规划者:脊灰11.1%,麻疹34.0%,白喉和破伤风5.5%。
  • 成人符合英国脊灰和麻疹免疫规划的几率显著低于儿童(OR分别为0.0013和0.29)。

核心结论

  • 抵达英国时,难民记录疫苗接种覆盖率不理想,且随年龄、国籍、健康评估国家和疾病不同而异,白喉和破伤风及成人难民覆盖率尤其低;研究强调需改进数据共享并明确东道国与健康评估提供方之间的责任划分。

研究设计与样本

  • 回顾性、基于人群的横断面研究,纳入2018年1月1日至2019年10月31日在18个国家接受IOM至少一次移民健康评估的所有赴英难民(儿童<10岁、青少年10-19岁、成人>19岁),共12526人。

主要发现

  • 研究纳入36个国籍的12526名难民,中位年龄17岁(IQR 7-33),女性6147人(49.1%),叙利亚籍7955人(63.5%)。
  • IOM共接种26118剂疫苗,最常见为麻疹、腮腺炎和风疹疫苗(8741剂)。
  • 研究期间6870名难民出发赴英,其中5556人(80.9%)至少有一剂含麻疹成分疫苗记录,5798人(84.4%)至少有一剂脊灰疫苗记录,1315人(19.1%)至少有一剂含白喉或破伤风成分疫苗记录。
  • 完全符合英国脊灰免疫规划者764人(11.1%),麻疹2338人(34.0%),白喉和破伤风380人(5.5%)。
  • 成人符合英国免疫规划的几率显著低于儿童:脊灰OR 0.0013(95%CI 0.0001-0.0052),麻疹OR 0.29(95%CI 0.25-0.32)。

关键数值与推荐

  • 含麻疹成分疫苗至少一剂记录覆盖率80.9%(5556/6870)。
  • 脊灰疫苗至少一剂记录覆盖率84.4%(5798/6870)。
  • 含白喉或破伤风成分疫苗至少一剂记录覆盖率19.1%(1315/6870)。
  • 完全符合英国免疫规划:脊灰11.1%(764/6870),麻疹34.0%(2338/6870),白喉和破伤风5.5%(380/6870)。
  • 成人vs儿童符合英国免疫规划的OR:脊灰0.0013(95%CI 0.0001-0.0052),麻疹0.29(95%CI 0.25-0.32)。

临床怎么用

  • 作者认为这些发现对难民入境前健康评估的实施以及针对英国和其他难民接收国儿童、青少年和成人移民的补种疫苗政策和交付具有重要影响。
  • 作者指出本研究强调需要改进数据共享,并更清晰地界定东道国与健康评估提供方之间的责任归属。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: WHO's new Immunization Agenda 2030 places a focus on ensuring migrants and other marginalised groups are offered catch-up vaccinations across the life-course. Yet, it is not known to what extent specific groups, such as refugees, are immunised according to host country schedules, and the implications for policy and practice. We aimed to assess the immunisation coverage of UK-bound refugees undergoing International Organization for Migration (IOM) health assessments through UK resettlement schemes, and calculate risk factors for under-immunisation. METHODS: We undertook a retrospective cross-sectional study of all refugees (children <10 years, adolescents aged 10-19 years, and adults >19 years) in the UK resettlement programme who had at least one migration health assessment conducted by IOM between Jan 1, 2018 and Oct 31, 2019, across 18 countries. Individuals' recorded vaccine coverage was calculated and compared with the UK immunisation schedule and the UK Refugee Technical Instructions. We carried out multivariate logistic regression analyses to assess factors associated with varying immunisation coverage. FINDINGS: Our study included 12 526 refugees of 36 nationalities (median age 17 years [IQR 7-33]; 6147 [49·1%] female; 7955 [63·5%] Syrian nationals). 26 118 vaccine doses were administered by the IOM (most commonly measles, mumps, and rubella [8741 doses]). During the study, 6870 refugees departed for the UK, of whom 5556 (80·9%) had at least one recorded dose of measles-containing vaccine and 5798 (84·4%) had at least one dose of polio vaccine, as per the UK Refugee Technical Instructions, and 1315 (19·1%) had at least one recorded dose of diphtheria-containing vaccine or tetanus-containing vaccine. 764 (11·1%) of refugees were fully aligned with the UK schedule for polio, compared with 2338 (34·0%) for measles and 380 (5·5%) for diphtheria and tetanus. Adults were significantly less likely than children to be in line with the UK immunisation schedule for polio (odds ratio 0·0013, 95% CI 0·0001-0·0052) and measles (0·29, 0·25-0·32). INTERPRETATION: On arrival to the UK, refugees' recorded vaccination coverage is suboptimal and varies by age, nationality, country of health assessment, and by disease, with particularly low coverage reported for diphtheria and tetanus, and among adult refugees. These findings have important implications for the delivery of refugee pre-entry health assessments and catch-up vaccination policy and delivery targeting child, adolescent, and adults migrants in the UK, and other refugee-receiving countries. This research highlights the need for improved data sharing and clearer definition of where responsibilities lie between host countries and health assessment providers. FUNDING: UK National Institute for Health Research (NIHR300072) and Medical Research Council (MR/N013638/1).

来源:Lancet Public Health,查看原文。版权归原作者所有。

引用

  1. Deal A, Hayward SE, Crawshaw AF, et al. Immunisation status of UK-bound refugees between January, 2018, and October, 2019: a retrospective, population-based cross-sectional study. Lancet Public Health. 2022. PMID: 35636439. doi:10.1016/S2468-2667(22)00089-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。